In her paperwork, Ms. DeVos said her stake in Theranos was valued at more than $1 million.
Theranos has drawn scrutiny from CMS and the FDA. The company has been sued multiple times over faulty blood tests, and federal prosecutors launched an investigation into the company in 2016 over allegations it misled investors by misrepresenting the readiness of its technologies and operations.
Ms. DeVos reported income from her Theranos holdings at less than $201.
More articles on healthcare finance:
5 latest hospital bankruptcies
Northwestern Memorial HealthCare’s operating income jumps 87%
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
